TYPE-2 NEUROFIBROMATOSIS - THE NEED FOR SUPRAREGIONAL CARE

被引:42
|
作者
EVANS, DGR
RAMSDEN, R
HUSON, SM
HARRIS, R
LYE, R
KING, TT
机构
[1] MANCHESTER ROYAL INFIRM, DEPT OTOLARYNGOL, MANCHESTER M13 9WL, LANCS, ENGLAND
[2] CHURCHILL HOSP, DEPT MED GENET, OXFORD OX3 7LJ, ENGLAND
[3] MANCHESTER ROYAL INFIRM, DEPT NEUROSURG, MANCHESTER M13 9WL, LANCS, ENGLAND
[4] LONDON HOSP, DEPT NEUROSURG, LONDON E1 1BB, ENGLAND
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 1993年 / 107卷 / 05期
关键词
NEUROFIBROMATOSIS; CENTRAL; NF2;
D O I
10.1017/S002221510012328X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The results of a U.K. study of 145 cases of type 2 neurofibromatosis has shown generally very poor operative results in terms of hearing and facial nerve preservation. Only 9 out of 118 vestibular schwannoma (acoustic neuroma) operations resulted in any clinically detectable hearing preservation and only 32 left the patient with good or normal (House grade I or II) ipsilateral facial nerve function. Although operation is still the definitive treatment of vestibular schwannoma (acoustic neuroma) and may be a lifesaving procedure, it appears that the evidence in favour of early operation is only valid when carried out in highly specialized centres. The special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf warrants a careful experienced approach. Timing of operations may be critical for the enhancement of useful years of quality life. We therefore propose the setting up of a national NF2 register, with the management of cases at a few supraregional centres.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [1] NEUROFIBROMATOSIS TYPE-2
    EVANS, DGR
    HARRIS, R
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 26 - 30
  • [2] NEUROFIBROMATOSIS TYPE-2
    THOMAS, G
    MEREL, P
    SANSON, M
    HOANGXUAN, K
    ZUCMAN, J
    DESMAZE, C
    MELOT, T
    AURIAS, A
    DELATTRE, O
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (13) : 1981 - 1987
  • [3] THE NEUROFIBROMATOSIS TYPE-2 GENE
    MARINEAU, C
    MEREL, P
    ROULEAU, GA
    THOMAS, G
    M S-MEDECINE SCIENCES, 1995, 11 (01): : 35 - 42
  • [4] RADIOLOGICAL INVESTIGATION OF NEUROFIBROMATOSIS TYPE-2
    AKESON, P
    HOLTAS, S
    NEURORADIOLOGY, 1994, 36 (02) : 107 - 110
  • [5] GENDER DIFFERENCES IN NEUROFIBROMATOSIS, TYPE-2
    SHORT, MP
    BOVE, C
    MACCOLLIN, M
    MOHNEY, T
    RAMESH, V
    TERENZIO, A
    GUSELLA, J
    NEUROLOGY, 1994, 44 (04) : A159 - A159
  • [6] LISCH NODULES IN NEUROFIBROMATOSIS TYPE-2
    CHARLES, SJ
    MOORE, AT
    YATES, JRW
    FERGUSONSMITH, MA
    ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (11) : 1571 - 1572
  • [7] NEUROFIBROMATOSIS TYPE-2 REVIEWED BY NEUROSURGEON
    HANINEC, P
    PLAS, J
    ZVERINA, E
    HOUSTAVA, L
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1995, 58 (05) : 240 - 243
  • [8] OCULAR FUNDUS IN NEUROFIBROMATOSIS TYPE-2
    LANDAU, K
    YASARGIL, GM
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (10) : 646 - 649
  • [9] THE RESTORATION OF HEARING IN NEUROFIBROMATOSIS TYPE-2
    LASZIG, R
    SOLLMANN, WP
    MARANGOS, N
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1995, 109 (05): : 385 - 389
  • [10] A CLINICAL-STUDY OF TYPE-2 NEUROFIBROMATOSIS
    EVANS, DGR
    NEARY, W
    HUSON, S
    NEWTON, V
    DONNAI, D
    HARRIS, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 46 - 46